FisherVista

A 1923 Maplewood home that sat untouched for 20 years sold for $1,188,000—48.5% over its $800,000 list price—after targeted renovations and staging, demonstrating the value of pre-market preparation for older properties.

Justin Mitchell, founder of Maryland Cash Home Buyers, has been selected by KeyCrew Media as a Verified Expert, providing market intelligence on cash purchasing and motivated seller dynamics across Maryland’s residential real estate market.

Commercial real estate owners are shifting from basic awareness to active planning for vertiport infrastructure, driven by eVTOL test flights and drone delivery expansions, with distributed energy solutions enabling more viable sites.

Families inheriting Mississippi properties often mistakenly assume informal authority before probate, leading to costly legal errors; experts recommend early consultation with a vetted probate attorney.

GlobalTech Corp. (OTC: GLTK) provided a shareholder update detailing its strategy to build a technology-centric holding company through acquisitions, platform commercialization, and a planned uplisting to the Nasdaq Capital Market.

The De Jong Self Storage Team at Colliers represented the buyer in the acquisition of a 291-unit self-storage facility in Ankeny, Iowa, a top-ranked suburb of Des Moines with strong demographic trends and limited new supply.

Dr. Robert Whitfield introduces a BII health program pairing explant surgery with fat transfer, supported by clinical safety research, as part of a broader health optimization initiative called the SHARP Method.

Canamera Energy Metals Corp. accelerates exploration at its Brazilian rare earth projects and files a technical report, positioning itself in the critical minerals sector as demand surges due to the energy transition.

Earth Science Tech Inc. (OTC: ETST) has repurchased 3.7 million shares over nine months, signaling a focus on shareholder value as it grows its telemedicine, pharmacy, and healthcare fulfillment businesses.

Quantum BioPharma Ltd. is progressing a diversified pipeline including a multiple sclerosis drug candidate and an alcohol metabolism accelerator, addressing unmet needs in neurological and wellness markets as neurological disorders become the leading cause of illness worldwide.

Trident Digital Tech Holdings Ltd. announced the launch of TDTHAI, an AI platform for enterprise deployment and digital transformation in Asia-Pacific, marking a key step in its strategy to build integrated digital infrastructure across emerging markets.

A peer-reviewed study in JACC: Advances shows that HeartBeam's credit card-sized ECG device, combined with a risk prediction algorithm, can accurately identify heart attack risk in patients with chest pain, achieving up to 92.9% accuracy with a baseline ECG.

BridgeCore Capital financed a McDonald's property in Saraland, Alabama, with a $1.4 million loan at 92% of purchase price, closing within 15 business days to meet the borrower's expedited timeline.

Dental implants remain the gold standard for tooth replacement, but costs can be daunting; this guide explains pricing factors, hidden fees, and strategies to save money without sacrificing quality.

Oncotelic Therapeutics and Sapu Nano have expanded their Phase 1b clinical program for Sapu003, appointing Global Clinical Trials as the lead CRO for international execution, marking a shift from an Australia-based study to a multinational development strategy.

TransCode Therapeutics announced Phase 1a results for TTX-MC138 showing no dose-limiting toxicities and durable disease stabilization in advanced cancer patients, supporting advancement to Phase 2a.

As AI data centers' electricity demand is projected to double by 2030, companies like MAX Power Mining are advancing natural hydrogen as a potential off-grid power source, with the company confirming North America's first subsurface natural hydrogen system.

Biotech companies are increasingly focusing on drug-delivery platforms to enhance existing cancer therapies, with the market projected to reach $410 billion, highlighting a strategic shift from new drug discovery to optimizing delivery methods.

A new pill, daraxonrasib from Revolution Medicines, targets the KRAS gene and has reportedly doubled survival in early trials for pancreatic cancer, a disease that has long resisted treatment.

Ferrari's announcement of its first fully electric vehicle, the Luce, has sparked significant pushback from investors and enthusiasts, highlighting concerns over the brand's shift from its traditional combustion-engine heritage.

Oncotelic Therapeutics is featured in a BioMedWire editorial discussing how biotech companies leverage advanced drug-delivery technologies, nanotechnology, and AI to enhance therapies, with implications for scalable platforms in oncology and rare diseases.